1. Review the strengths and weaknesses of the recent BLISS-LN trial.
2. Discuss the applicability of the trial's findings.
3. Integrate these findings into our current understanding of lupus nephritis management.
10/20/2020 - 8:30am to 9:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Emily Peninger, M.D.